Experts hope the information gained from their research could help providers better determine whether patients will regain mobility after sustaining an injury. 

If 25% tariffs go into effect, it could have a big impact on the cost of medical imaging and radiotherapy systems, with many manufacturing facilities in Mexico. 

There are numerous radiotracers specifically designed to identify prostate cancer, but experts say one may be superior to the others at both the patient and lesion level. 

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.

Post-traumatic epilepsy can be disabling, causing recurrent seizures that are unresponsive to preventive medications in up to 30% of patients.

Recent projections could create an environment of unprecedented demand for nuclear imaging.

The new appropriate use criteria define 17 specific clinical scenarios, guiding providers on situations when amyloid or tau imaging are and are not appropriate.

Use of the new tracer could improve outcomes by enabling providers to adjust treatment regimens much earlier than they have been able to previously.